Hualan Biological Vaccine Inc.

XSEC:301207 Stock Report

Market Cap: CN¥11.4b

Hualan Biological Vaccine Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Wenjue An

Chief executive officer

CN¥343.3k

Total compensation

CEO salary percentagen/a
CEO tenure2.7yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO

Wenjue An (35 yo)

2.7yrs

Tenure

CN¥343,300

Compensation

Ms. An Wenjue is GM & Director of Hualan Biological Vaccine Inc. (formerly known as Hualan Biological Bacterin Inc.) from April 28, 2022. She was Deputy General Manager of Hualan Biological Vaccine Inc. (f...

Board Members

NamePositionTenureCompensationOwnership
Wenjue An
GM & Director2.6yrsCN¥343.30kno data
Ruowen Pan
Deputy GM & Director4.4yrsCN¥906.80kno data
Kang An
Non-Independent Chairman4.4yrsno datano data
Bei Fan
Non-Independent Director4.4yrsno datano data
Xiaowei Ma
Non-Independent Director4.4yrsno datano data
Wenqi An
Non-Independent Director4.4yrsno datano data
Dexin Li
Independent Director4.4yrsCN¥100.00kno data
Guanmu Dong
Independent Director4.4yrsCN¥100.00kno data
Yang Dong Sheng
Independent Director4.4yrsCN¥100.00kno data
Chaoyuan Ma
Non-Employee Supervisor4.4yrsno datano data
Yuancheng Lou
Supervisory Board Chairman4.4yrsno data0.00023%
CN¥ 26.2k

4.4yrs

Average Tenure

56yo

Average Age

Experienced Board: 301207's board of directors are considered experienced (4.4 years average tenure).